Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 12/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29767847 | 1.00 | AHCY (1.00) | AHCYADORA2AADORA3 | |
| SCHEMBL12280626 | 1.00 | AHCY (1.00) | AHCYADORA2AADORA3 | |
| SCHEMBL29374741 | 1.00 | AHCY (1.00) | AHCYADORA2AADORA3 | |
| SCHEMBL2418669 | 1.00 | AHCY (1.00) | AHCYADORA2AADORA3 | |
| SCHEMBL10010471 | 1.00 | AHCY (1.00) | AHCYADORA2AADORA3 | |
| SCHEMBL27003100 | 0.83 | AHCY (0.71) | AHCYADORA2AADORA3 | |
| SCHEMBL14028190 | 0.82 | AHCY (0.70) | AHCYADORA2AADORA3 | |
| SCHEMBL4952005 | 0.82 | AHCY (0.70) | AHCYADORA2AADORA3 | |
| SCHEMBL26804582 | 0.82 | AHCY (0.70) | AHCY | |
| SCHEMBL29706988 | 0.78 | AHCY (0.64) | AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3427755-B1 | HPV PARTICLES AND USES THEREOF | INST NAT SANTE RECH MED (FR) | 2020-10-21 | — | — | EP | disclosed |
| US-10688172-B2 | HPV particles and uses thereof | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-06-23 | — | — | US | disclosed |
| US-10596275-B2 | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells | AURA BIOSCIENCES, INC. (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190275176-A1 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS | AURA BIOSCIENCES, INC. (US) | 2019-09-12 | — | — | US | disclosed |
| US-10300150-B2 | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells | AURA BIOSCIENCES, INC. (US) | 2019-05-28 | — | — | US | disclosed |
| US-20190142925-A1 | HPV PARTICLES AND USES THEREOF | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2019-05-16 | — | — | US | disclosed |
| EP-3427755-A1 | HPV PARTICLES AND USES THEREOF | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2019-01-16 | — | — | EP | disclosed |
| US-10179168-B2 | HPV particles and uses thereof | INSERM (Institut National de la Santé et de la Recherche Médicale (FR) | 2019-01-15 | — | — | US | disclosed |
| EP-2419143-B1 | HPV PARTICLES AND USES THEREOF | INST NAT SANTE RECH MED (FR) | 2018-05-09 | — | — | EP | disclosed |
| US-20180110883-A1 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS | AURA BIOSCIENCES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| US-20170274099-A1 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS | AURA BIOSCIENCES, INC. (US) | 2017-09-28 | — | — | US | disclosed |
| US-9724404-B2 | HPV particles and uses thereof | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-08-08 | — | — | US | disclosed |
| US-9700639-B2 | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells | AURA BIOSCIENCES, INC. (US) | 2017-07-11 | — | — | US | disclosed |
| US-20140377170-A1 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS | AURA BIOSCIENCES, INC. (US) | 2014-12-25 | — | — | US | disclosed |
| WO-2013119877-A1 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS | AURA BIOSCIENCES, INC. (US) | 2013-08-15 | — | — | WO | disclosed |
| US-20130012566-A1 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia | AURA BIOSCIENCES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-20120171290-A1 | HPV PARTICLES AND USES THEREOF | AURA BIOSCIENCES, INC. | 2012-07-05 | — | — | US | disclosed |
| EP-2419143-A1 | HPV PARTICLES AND USES THEREOF | INSERM - Institut National de la Santé et de la Recherche Médicale (FR) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010120266-A1 | HPV PARTICLES AND USES THEREOF | INSERM, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2010-10-21 | — | — | WO | disclosed |
| US-4859677-A | Nucleoside analogues having antiviral activity | UNIVERSITY OF KANSAS (US) | 1989-08-22 | — | — | US | disclosed |